Abe Y, Ijichi N, Ikeda K, Kayano H, Horie-Inoue K, Takeda S, Inoue S.

Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells.

Cancer Sci. 103: 806-812, 2012
 

　S, Sakamoto A, Nagaoka K, Anan K, Wang Y, Mimasu S, Umehara T,　
　Yokoyama S, Kosai K, and Nakao M.　　

　FAD-dependent lysine-specific demethylase-1 regulates cellular energy
　expenditure.

　Nat. Commun. 3,758, 2012.
　

 　  Okabe Y, Takahashi T, Mitsumasu C, Kosai K, MD, Tanaka E, Matsuishi T.

 　  Alterations of Gene Expression and Glutamate Clearance in Astrocytes

 　  Derived from an MeCP2-null Mouse Model of Rett Syndrome.

  　 PLoS ONE. 7(4):e35354, 2012.
　　

Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Horm Cancer 3: 147-159, 2012

　　Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S,
　　Maezono R, Kosai K, Takamatsu H.

　　Therapeutic effects of vitamin A on experimental cholestatic rats with
　　hepatic fibrosis.

　　Pediatr Surg Int. 27(8):863-70, 2011
　

Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

Horm Cancer. 2: 286-297. 2011

Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S.

Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.

J Steroid Biochem Mol Biol. 123: 1-7. 2011

　　Kamisasanuki T, Wang Y, Tokushige S, Terasaki H, Khai NC, Wang Y,
　　Sakamoto T, Kosai K.

　　Targeting CD9 produces stimulus-independent antiangiogenic effects
　　predominantly in activated endothelial cells during angiogenesis: A novel
　　antiangiogenic therapy.

　 　                      Biochem. Biophys. Res. Commun. 16;413(1):128-35, 2011　　

　Horikawa Y, Wang Y, Nagano S, Kamizono J, Ikeda M, Komiya S, Kosai K.

　Assessment of an altered E1B promoter on the specificity and potency of
　triple-regulated conditionally replicating adenoviruses (CRA) ⎯Implications
　for the generation of ideal m-CRAs.

　Cancer Gene Ther 18(10):724-33, 2011

　Khai NC, Sakamoto K, Takamatsu H, Matsufuji H, Kosai K.

　Recombinant soluble form of HB-EGF protein therapy drastically
　inhibits Fas-mediated fulminant hepatic failure: Implications in clinical
　application.

　Hepatol Res. 41:594-596, 2011.